Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SsRI/NIE Recombinant Antigen ELISA for the Follow up of Patients Infected by Strongyloides Stercoralis

NCT06308705 is registered in ClinicalTrials.gov with IRCCS Sacro Cuore Don Calabria di Negrar as lead sponsor.

NCT NCT06308705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06308705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SsRI/NIE Recombinant Antigen ELISA for the Follow up of Patients Infected by Strongyloides Stercoralis
Lead sponsor
IRCCS Sacro Cuore Don Calabria di Negrar
Phase
Not applicable
Overall status
Completed
Start date
June 6, 2023
Completion date
October 18, 2023
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

strongyloides stercoralis infection